Nuclear SOX2 levels were largely and statistically significantly higher in lung SCCs (n = 109, set I; n = 177 set II) relative to the levels in adenocarcinomas (set I, n = 178; set II, n = 334) (both p<0.001) (Figure 3A). This evidence concerns the gene SOX2 and adenocarcinoma.